Ataxia therapeutic compositions and methods
A method for treating a subject having, or at risk of having, ataxia, generally includes administering to the subject an amount of a composition comprising a cholecystokinin receptor (Cck1R) agonist effective to ameliorate at least one symptom or clinical sign of ataxia.
1. A method for treating a subject having, or at risk of having, ataxia, the method comprising:
administering to the subject having, or at risk of having, ataxia an amount of a composition comprising a cholecystokinin receptor (Cck1R) agonist effective to ameliorate at least one symptom or clinical sign of ataxia.
2. The method of claim 1 wherein the Cck1R agonist is A71623.
3. The method of claim 2 wherein A71623 is administered to the subject to provide a dose of at least 20 μg/kg/day.
4. The method of claim 3 wherein the dose of A71623 is 1 mg/kg/day.
5. The method of claim 1 wherein the Cck1R agonist is rebamipide.